Home
Viela Bio

Viela Bio Market Share Analysis for February 2026

we're horizon, a global biotechnology company driven by a simple idea: we believe that science and compassion must work together to transform lives.

Health > Biotechnology and Pharmaceuticals

Domainvielabio.com

Year Founded2017

Employees51 - 200

Annual Revenue$200M - $500M

Viela Bio

Viela Bio (including company regionals)

vielabio.com

See more website traffic and engagement information

Viela Bio Revenue up to February 2026 is 200M - 500M

revenue generated by Viela Bio top domains

Viela Bio top domains revenue over 3 years

Revenue for Viela Bio top domains

vielabio.com200M - 500M

See more with Sales Intelligence

Total visits to Viela Bio's top domains

Understand Viela Bio market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Viela Bio's top domains

Analyze Viela Bio engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Viela Bio's top domains

See how Viela Bio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Viela Bio top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Viela Bio

These are the website technologies, by industry, used by Viela Bio top domains

Advertising (7)

DoubleClick

Widget (5)

Twemoji

Conversion & Analytics (4)

Google Analytics

Social (3)

Instagram

More Technologies

9

See all

News & Signals from Viela Bio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsUplizna acquired Viela Bio, Inc. for $3.05B on Jan 1st '21.Management asks themselves whether they can add value to what they receive, such as Uplizna and the 2021 deal to acquire Viela Bio for $3.05 billion with opportunity inherited to expand to additional indications.

NewsHorizon Therapeutics plc acquired Viela Bio, Inc. for $3.1B on Jan 1st '21.Photo: Horizon Therapeutics Dublin-based Horizon Therapeutics is expanding in Montgomery County, Md., on the heels of last year’s acquisition of Gaithersburg, Md.-based Viela Bio, another biotech company.

NewsJim Kastenmayer leaves Viela Bio, Inc. as general counsel.Mr. Kastenmayer joins Aeglea from Viela Bio, where, as general counsel, he provided strategic guidance and legal advice including advising the company in connection with the FDA approval and launch of Uplizna® as well as the company's acquisition by Horizon Therapeutics.